Drawing for WERFEN

USPTO serial 79338630

WERFEN

Reviewed by CopyMark Law Group

Reg. 7128982Status 700Registered
Filing date
Status date
Registration date
Aug 8, 2023
Examiner
BODRI, KRISTIN MARIE
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with WERFEN?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Deborah J. Peckham

Deborah J. Peckham Barclay Damon LLP160 Federal Street, Suite 1001Boston, MA 02110United States

Goods and services

ClassDescriptionStatusFirst use
005Diagnostic reagents for medical or veterinary use; immunoassay reagents for medical or veterinary use; medical reagents for clinical use; reagents for clinical analysis for medical or veterinary use; reagents for microbiological analysis for medical or veterinary use; reagents for use in analyzers for medical or veterinary purposes; reagents for in-vitro use in laboratories for medical or veterinary purposes; chemical reagents for testing for medical or veterinary useACTIVE—
009Scientific, optical, weighing, measuring and checking apparatus and instruments, namely, Research laboratory analyzers for measuring, testing and analyzing blood and other bodily fluids, Diagnostic apparatus for the detection of pathogens for laboratory or research use, Flow cytometers and flow-based analyzers providing cell and particle analysis, detection, or counting for scientific, laboratory, and general research uses, Laboratory instrument for the detection of pathogens and toxins in a biological sample for research use, Laboratory devices for analyzing protein sequence, Laboratory devices for analyzing genome information, Electronic analyzers for testing and analyzing chemical and biological substances for the presence, absence, or quantity of target chemicals, biologics or contaminants, Chromatography apparatus for laboratory use, Laboratory apparatus and chromatography systems for use in protein purification, Bioreactors for laboratory use, Scientific apparatus and instruments for measuring relative DNA, RNA and protein and parts and fittings therefor, X-ray fluorescence analyzers, Fluorescence microscopes, Laboratory equipment and supplies, namely, incubators, Laboratory photochemical reactors, Laboratory devices for detecting genetic sequences, Spectrograph apparatus; data processing equipment, computers; downloadable software, specifically computer applications and computer programs intended for laboratory information systems, data management for specific clinical applications, comprehensive solutions for communication, clinical diagnostics and patient-focused systems, such as management of therapies, chronic disorders and telemedicineACTIVE—
010Medical apparatus and instruments for analysis in laboratories and clinical diagnosis of human diseases in the form of automated coagulation analyzers, namely, electronic instruments for measuring the characteristics and components of blood clots; medical apparatus and instruments for analysis in laboratories and clinical diagnosis of human diseases in the form of automated bodily fluid analyzers, namely, automated instruments for measuring blood gases, hematocrit, hemoglobin, and electrolytes; medical apparatus and instruments for analysis in laboratories and clinical diagnosis of human diseases in the form of disposable cartridges containing reagents for diagnostic testing of bodily fluids in an automated bodily fluid analyzer; medical apparatus and instruments for analysis in laboratories and clinical diagnosis of human diseases in the form of automatic clinical analyzers, namely, electronic instruments for measuring the partial pressure of oxygen and carbon dioxide and ionic activity in the bloodACTIVE—
035Retail store services offering products, apparatus and instruments for in-vitro analysis and diagnosis, kits comprising receivers for samples and reagents for testing selected bacteria, equipment for biomolecular tagging consisting of reagents for use in scientific research, mixtures of chemical reagents in kits, other than those for medical or veterinary use, mixtures of chemical reagents, not for medical or veterinary use, testing reagents for scientific use, monoclonal antibody reagents for medical use, diagnostic reagents, other than for use in medical laboratories, diagnostic reagents for scientific or research use, assay reagents, other than those for medical use, assay reagents for industrial use, immunoassay reagents, other than those for medical use, laboratory reagents for scientific use, reagents for microbiological analysis not for medical or veterinary use, reagents for chemical analysis, reagents for research, reagents for medical research, reagents for use in immunoserology, reagents for use in scientific apparatus for chemical or biological analysis, reagents for use with analyzers, other than for medical or veterinary use, diagnostic reagents for medical or veterinary use, immunoassay reagents for medical or veterinary use, medical reagents for clinical use, reagents for clinical analysis for medical or veterinary use, reagents for microbiological analysis for medical or veterinary use, reagents for use in analyzers for medical or veterinary use, reagents for in-vitro use in laboratories for medical or veterinary use, chemical reagents for testing for medical or veterinary use, computer applications and computer programs intended for laboratory information systems, data management for specific clinical applications, comprehensive solutions for communication, clinical diagnosis and patient-focused systems, such as management of therapies, chronic disorders and telemedicine, medico-surgical products for use in the hospital sector, scientific, analytical and laboratory apparatus and instruments, instruments; procurement services, namely, acquisition of products for third parties in the form of in-vitro diagnosis and analysis products, apparatus and instruments, kits comprising receivers for samples and reagents for testing selected bacteria, equipment for biomolecular tagging consisting of reagents for use in scientific research, mixtures of chemical reagents in kits, other than those for medical or veterinary use, mixtures of chemical reagents, not for medical or veterinary use, testing reagents for scientific use, monoclonal antibody reagents for medical use, diagnostic reagents, other than for use in medical laboratories, diagnostic reagents for scientific or research use, assay reagents, other than those for medical use, assay reagents for industrial use, immunoassay reagents, other than those for medical use, laboratory reagents for scientific use, reagents for microbiological analysis not for medical or veterinary use, reagents for chemical analysis, reagents for research, reagents for medical research, reagents for use in immunoserology, reagents for use in scientific apparatus for chemical or biological analysis, reagents for use with analyzers, other than for medical or veterinary use, diagnostic reagents for medical or veterinary use, immunoassay reagents for medical or veterinary use, medical reagents for clinical use, reagents for clinical analysis for medical or veterinary use, reagents for microbiological analysis for medical or veterinary use, reagents for use in analyzers for medical or veterinary use, reagents for in-vitro use in laboratories for medical or veterinary use, chemical reagents for testing for medical or veterinary use, computer applications and computer programs intended for laboratory information systems, data management for specific clinical applications, comprehensive solutions for communication, clinical diagnosis and patient-focused systems, such as management of therapies, chronic disorders and telemedicine, medico-surgical products for use in the hospital sector, scientific, analytical and laboratory apparatus and instruments, instruments; import-export agencies in the field of in-vitro diagnosis and analysis products, apparatus and instruments, kits comprising receivers for samples and reagents for testing selected bacteria, equipment for biomolecular tagging consisting of reagents for use in scientific research, mixtures of chemical reagents in kits, other than those for medical or veterinary use, mixtures of chemical reagents, not for medical or veterinary use, testing reagents for scientific use, monoclonal antibody reagents for medical use, diagnostic reagents, other than for use in medical laboratories, diagnostic reagents for scientific or research use, assay reagents, other than those for medical use, assay reagents for industrial use, immunoassay reagents, other than those for medical use, laboratory reagents for scientific use, reagents for microbiological analysis not for medical or veterinary use, reagents for chemical analysis, reagents for research, reagents for medical research, reagents for use in immunoserology, reagents for use in scientific apparatus for chemical or biological analysis, reagents for use with analyzers, other than for medical or veterinary use, diagnostic reagents for medical or veterinary use, immunoassay reagents for medical or veterinary use, medical reagents for clinical use, reagents for clinical analysis for medical or veterinary use, reagents for microbiological analysis for medical or veterinary use, reagents for use in analyzers for medical or veterinary use, reagents for in-vitro use in laboratories for medical or veterinary use, chemical reagents for testing for medical or veterinary use, computer applications and computer programs intended for laboratory information systems, data management for specific clinical applications, comprehensive solutions for communication, clinical diagnosis and patient-focused systems, such as management of therapies, chronic disorders and telemedicine, medico-surgical products for use in the hospital sector, scientific, analytical and laboratory apparatus and instruments, instrumentsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 13, 2025NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jun 18, 2025TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jun 18, 2025ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 18, 2025REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jun 18, 2025CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jun 18, 2025COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Dec 3, 2023FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Nov 9, 2023FICSFINAL DISPOSITION NOTICE SENT TO IB—
Nov 9, 2023FIMPFINAL DISPOSITION PROCESSED—
Nov 8, 2023FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Aug 8, 2023NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Aug 8, 2023R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
May 23, 2023GPNXNOTIFICATION PROCESSED BY IB—
May 23, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 23, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 3, 2023OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
May 3, 2023OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
May 3, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 14, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 24, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 24, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 24, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 25, 2023RFNPREFUSAL PROCESSED BY IB—
Dec 29, 2022RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Dec 28, 2022RFRRREFUSAL PROCESSED BY MPU—
Dec 24, 2022NREPNEW REPRESENTATIVE AT IB RECEIVED—
Oct 23, 2022ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Oct 13, 2022RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Oct 12, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 5, 2022DOCKASSIGNED TO EXAMINER—
May 7, 2022MAFRAPPLICATION FILING RECEIPT MAILED—
May 3, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 28, 2022LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
Apr 21, 2022REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance